Global Aging Trends Will Expand Biosimilars And Generics Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 39 Analysts
Published
15 Jun 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
₹1,621.36
21.2% undervalued intrinsic discount20 Aug
₹1,277.00
1Y
-8.2%7D
1.4%